Skip to main content
logo
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.030
-0.110 (-5.14%)
At close: Nov 7, 2025, 4:00 PM EST
2.080
+0.050 (2.46%)
After-hours: Nov 7, 2025, 5:13 PM EST

Aytu BioPharma Revenue

In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth. Aytu BioPharma had revenue of $15.14M in the quarter ending June 30, 2025, with 3.71% growth.

Revenue (ttm)
$66.38M
Revenue Growth
+1.84%
P/S Ratio
0.19
Revenue / Employee
$799,783
Employees
83
Market Cap
20.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202566.38M1.20M1.84%
Jun 30, 202465.18M-8.62M-11.67%
Jun 30, 202373.80M-22.87M-23.66%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

AYTU News

More News